Organic Chemistry Methods TRIZ Cases

Cooling propylene to 0-50°C separates water and organic impurities, preventing catalyst destruction and pressure loss in the reactor.

A deuterated organic compound combines phenanthroline and anthracene moieties to enhance electron transport in display devices.

Irradiation induces cis-trans isomerization in anthracene derivatives, enabling controlled delamination of 200-600 nm layers for self-renewable surfaces.

DNA-PK inhibitors target quiescent cancer stem cells by blocking the NHEJ pathway, overcoming radioresistance and improving treatment efficacy.

Polymorphic forms of Compound 1 improve drug stability and solubility to overcome viral mutation resistance.

Crystalline Forms III and V of Rucaparib tosylate resolve compressibility and solubility trade-offs for cancer treatment formulations.

Deuterium substitution stabilizes metabolic bonds to extend half-life, improving tumor inhibition when combined with PD-1 inhibitors.

Deuterium-substituted pyrrolotriazine compounds inhibit mutant KIT and PDGFRα kinases with high selectivity.

Crystalline N-methyl tryptamine derivatives provide stable solid-state forms for pharmaceutical use.

Molybdenum vanadium niobium antimony oxide catalyst enables high yield production of unsaturated acids through simplified drying and calcination steps.

Sodium periodate oxidation of aryl compounds yields crystalline diaryliodonium salt mixtures with improved monomer solubility.

A nitrogen-containing compound with a carbazole structure and fluorenyl group serves as an organic electroluminescent host material.

Tetrahydroisoquinoline derivatives selectively potentiate GluN2C and GluN2D subunits to improve cognitive function while reducing severe side effects.

A three-compound light emitting layer uses optimized energy relationships to enhance emission efficiency in organic electroluminescent devices.

Deuterium substitution on the core structure increases electronic stability, resolving the trade-off between high device efficiency and operational lifetime.

Anthracene compound with asymmetric substituents stabilizes molecular structure in emission layers.

Thermal cycling converts selinexor Form A to Form ZL, resolving stability and hygroscopicity issues for pharmaceutical manufacturing.

Controlled cooling of valomaciclovir in lower alkanols yields stable Polymorph A, resolving agglomeration and poor flowability for reliable oral dosing.

Water extractant in distillation column separates acetaldehyde from methyl iodide, reducing energy consumption and distillation stages.

Unsaturated ester precursors undergo para-hydrogenation to transfer polarization directly to the 13C carboxylate carbon atom, bypassing complex DNP equipment.

Composite materials with deuterium substitution extend organic EL device lifetime by reducing non-radiative decay rates.

A deuterated organometallic compound uses a bridged carbene ligand to enhance hole and electron transport in organic light-emitting devices.

A naphthobenzofuran heterocyclic compound regulates band gap and T1 values to enhance electron transfer and hole blocking capabilities.

Enzymatic hydrolysis replaces harsh alkalis to extract high-purity lutein crystals with over 80% yield and minimal environmental impact.

Novel Remimazolam synthesis replaces hazardous cryogenic reagents with safe oxidants, enabling industrial scale production.

Melt crystallization separates dialkyl esters from monoalkyl contaminants, achieving 99.5% purity without complex distillation steps.

MDM2 inhibitors restore p53 function to treat myeloproliferative neoplasms resistant to Ruxolitinib.

Modified alkynylene compounds reduce chemotherapy side effects by selectively inhibiting EGFR signaling and BCR pathway components.

Prodrugs activate DNA-PK inhibition only in hypoxic tissue to kill resistant cancer cells while sparing normal tissues.